EISAI-E7389-G000-309

Study Sponsor: Eisai

Study Title

A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma

Medicine or Vaccine (generic name)

eribulin mesilate

Sponsor Identification Number

E7389-G000-309

Trial Registry Identification Number(#'s)

NCT01327885
EU CTR 2010-024483-17

Medical Condition

Soft Tissue Sarcoma

Phase

Phase 3

Link to study details on the Eisai Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/ct2/show/NCT01327885

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2010-024483-17

Datasets and Documents Available for this Study

Additional information about the data and documents available for this study

No restrictions

Date Added to this Site

November 2017